Definium Therapeutics, Inc. Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount
Definium Therapeutics, Inc. (DFTX) reported Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount of -$11.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount · last filed 2026-02-26
- Definium Therapeutics, Inc. effective income tax rate reconciliation cross border tax effect amount for fiscal 2025 was -$11.00K.
| Period end | Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount 12 month |
|---|---|
| 2025-12-31 | -$11.00K 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |